Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Skin treatment can lower life quality for patients with skin conditions.

COVID-19 can cause different skin issues, including rashes and hair loss.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

White hair follicles in vitiligo have fewer and less functional melanocytes.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.